Canada · Delayed Price · Currency is CAD Pharmadrug Company Description
Pharmadrug Inc. operates as a specialty pharmaceutical company.
The company focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs.
It also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs for potential commercialization and distribution; development of cepharanthine, a drug for the treatment of infectious disease and rare cancers; and research and development activities in the psychedelics space for the treatment of non-neuropsychiatric conditions.
It has a license agreement with Southwest Research Institute. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019.
Pharmadrug Inc. was incorporated in 2011 and is based in Toronto, Canada.
| Country | Canada |
| Founded | 2011 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Robert Steen |
Contact Details
Address: 77 King Street West Toronto, Ontario M5K 1H1 Canada | |
| Phone | 647 202 1824 |
| Website | pharmadrug.ca |
Stock Details
| Ticker Symbol | PHRX |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA71716W2040 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Dr. David M. Kideckel M.B.A., MBA, Ph.D. | Executive Chairman of the Board |
| Kyle Michael Appleby CA, CPA | Chief Financial Officer |